Improving imaging techniques for better diagnosis and treatment of colorectal cancer
Integrating highly multiplexed immunofluorescence with label-free 2D hyperspectral chemical imaging to interrogate the colorectal cancer tumor-invasive front
This study is working on a new way to help doctors find colorectal cancer more accurately by using special imaging techniques, which could lead to better treatment and outcomes for patients like you.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-10997114 on NIH RePORTER |
What this research studies
This research focuses on enhancing the accuracy of diagnosing colorectal cancer by integrating advanced imaging techniques. It aims to develop a new method that combines highly multiplexed immunofluorescence with label-free hyperspectral chemical imaging to better identify cancerous tissues. By characterizing the unique chemical signatures of tumors, the research seeks to improve surgical outcomes and tailor therapies to individual patients. This innovative approach could lead to more precise identification of tumor-positive tissues, which is crucial for effective treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with colorectal cancer who are undergoing treatment or surgical intervention.
Not a fit: Patients with non-colorectal cancers or those who are not undergoing any form of treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate diagnoses and improved treatment options for colorectal cancer patients.
How similar studies have performed: Previous research has shown promise in using advanced imaging techniques for cancer diagnostics, suggesting that this approach could yield significant advancements.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Holman, Elizabeth a — Stanford University
- Study coordinator: Holman, Elizabeth a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.